Lineage Cell Therapeutics Inc (LCTX)

[DeepDive]

$BTX DD links for AST-OPC1

Reminder:
a. $BTX owns $AST.
b. AST- OPC1 is the same treatment that gave a man with spinal cord injury the ability to use hands and arms, after just 10 million cells treatment. Last PR is double the amount.

List of Helpful links about the Biotime and Atrerias OPC-1 for DD purposes and new Shareholders:

- A video explaining about the company & therapies developed (2016)

- https://t.co/RZTWEgWTBK: The Official Blog of CIRM (California Stem Cell Agency).

- Paralyzed Man Regains Use of Arms and Hands After Experimental Stem Cell Therapy at Keck Hospital of USC. Initial Results Offer Hope for Patients to Reclaim Independence After Suffering Severe Spinal Injury. https://t.co/d0uLdABDAp

- A video taken documenting the remarkable results of Kristopher (Kris) Boesne, one of the participants in the 10 million cohort of AST-OPC1:

- Upper- and Lower-Extremity Motor Recovery After Traumatic Cervical Spinal Cord Injury: An Update From the National Spinal Cord Injury Database. https://t.co/GZJYVrFeoq